AppPriceData観測済みデータ
AppPriceData
American Society for Colposcopy and Cervical Pathology
The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios.
現在選択しているストアで観測したダウンロード価格です。地域別価格を開くと、国ごとの換算価格を比較できます。
Apple の公開 App Store ページで現在確認できる項目です。App Store Connect の完全な商品一覧とは限りません。
The ASCCP Risk-Based Management Consensus Guidelines provide evidence-based recommendations for managing abnormal cervical cancer screening results and cancer precursors, including post-colposcopy and post-treatment scenarios.
ASCCP is pleased to offer this app to streamline navigation of the ASCCP Risk-Based Management Consensus Guidelines for abnormal cervical cancer screening tests and cancer precursors. The guidelines articles, as published in the Journal of Lower Genital Tract Disease, as well as the comprehensive risk estimates, can be accessed through https://www.asccp.org/guidelines.
These evidence-based management guidelines, initially developed in 2019, came together through a consensus process of 19 organizations. The updated management guidelines aim to:
• Allow for a more complete and precise estimation of risk
• Provide more appropriate intervention for high-risk individuals (detect and treat more precancer)
• Recommend less intervention for low-risk individuals (decrease testing and treatment that won’t prevent cancer and may cause reproductive harm)
• Allow for the future addition of new risk modifiers and screening and management technologies
See https://www.asccp.org/UserGuide for tips on using the app.
最新の App Store 観測データに基づく回答です。
最新の観測ダウンロード価格は ¥2,500 です。現在の決済価格は公式 App Store リンクで確認してください。
Apple の公開ページでは現在、このストアで 0 件の購入項目が表示されています。公開一覧は完全ではない場合があります。
はい。App Store の価格はストア、通貨、税、開発者の価格設定によって異なる場合があります。現在 20 地域の観測データがあります。
